Rockley Photonics Shares Pop On Preliminary Human Studies Results

Rockley Photonics Holdings Ltd RKLY completed the first stages of its preliminary human studies, examining the measurement of core body temperature using its non-invasive biomarker sensing platform.
Rockley's sensing platform has the potential to provide real-time insights about multiple health conditions by allowing the detection of core body temperature from a wearable device like a smartwatch or wristband.
The Rockley sensing platform uses photonic integrated circuit sensors to generate numerous discrete, narrow-linewidth laser wavelengths across a wide spectral range.
Rockley's in-house core body temperature studies represent the first in a series of studies designed to evaluate and refine the performance of Rockley's biomarker sensing platform in measuring a wide range of biomarkers.
Price Action: RKLY shares traded higher by 8.05% at $5.90 on the last check Wednesday.